UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease

PloS one, 2010-12, Vol.5 (12), p.e14192-e14192

2010

Volltextzugriff (PDF)

Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion

Stem cells (Dayton, Ohio), 2004-09, Vol.22 (5), p.675-682

2004

Volltextzugriff (PDF)

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

Blood, 2004-11, Vol.104 (9), p.2643-2645

2004

Volltextzugriff (PDF)

Improved Metabolic Correction in Patients with Lysosomal Storage Disease Treated with Hematopoietic Stem Cell Transplant Compared with Enzyme Replacement Therapy

The Journal of pediatrics, 2009-04, Vol.154 (4), p.609-611

2009

Volltextzugriff (PDF)

Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB

Behavioural brain research, 2010-06, Vol.209 (2), p.212-220

2010

Volltextzugriff (PDF)

Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier

PloS one, 2013-10, Vol.8 (10), p.e77632

2013

Volltextzugriff (PDF)

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases

Journal of inherited metabolic disease, 2011-04, Vol.34 (2), p.499-508

2011

Volltextzugriff (PDF)

Evaluation of heparin cofactor II–thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice

Molecular genetics and metabolism, 2010-03, Vol.99 (3), p.269-274

2010

Volltextzugriff (PDF)

Retrovirally mediated correction of bone marrow–derived mesenchymal stem cells from patients with mucopolysaccharidosis type I

Blood, 2002-03, Vol.99 (5), p.1857-1859

2002

Volltextzugriff (PDF)

Enzyme Replacement Therapy and Extended Newborn Screening for Mucopolysaccharidoses: Opinions of Treating Physicians

JIMD Reports - Case and Research Reports, 2011/1, 2011-01, Vol.1, p.9-15

2011

Volltextzugriff (PDF)

Laronidase treatment of mucopolysaccharidosis I

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2005, Vol.19 (1), p.1-7

2005

Volltextzugriff (PDF)

Limitations of enzyme replacement therapy: Current and future

Journal of inherited metabolic disease, 2006-04, Vol.29 (2-3), p.442-447

Wraith, J. E.

2006

Volltextzugriff (PDF)

The majority of MPS I patients tested raise inhibitory allo-antibodies against enzyme replacement therapy

Molecular genetics and metabolism, 2013-02, Vol.108 (2), p.S81-S81

2013

Volltextzugriff (PDF)

Excess Heparan Sulphate Inhibits CXCL12-Mediated Hematopoietic Cell Migration and Engraftment After Bone Marrow Transplant in Mice with Mucopolysaccharidosis Type I

Blood, 2011-11, Vol.118 (21), p.4010-4010

2011

Volltextzugriff (PDF)

Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I

Acta Paediatrica, 2005-07, Vol.94 (7), p.872-877

2005

Volltextzugriff (PDF)

Signal One and Two Blockade Are Both Critical for Non-Myeloablative Murine HSCT across a Major Histocompatibility Complex Barrier: e77632

PloS one, 2013-10, Vol.8 (10)

2013

Volltextzugriff (PDF)

Novel Mutations in Sanfilippo a Syndrome: Implications for Enzyme function

Human molecular genetics, 1997-09, Vol.6 (9), p.1573-1579

1997

Volltextzugriff (PDF)

Cellular Therapy of Lysosomal Storage Disorders: Current Status and Future Prospects

Current pediatric reviews, 2009-08, Vol.5 (3), p.147-159

2009

Volltextzugriff (PDF)

Mucopolysaccharidoses and Oligosaccharidoses

Inborn Metabolic Diseases, p.495-507

Volltextzugriff (PDF)

Treatment: Present Status and New Trends

Inborn Metabolic Diseases, p.81-97

Volltextzugriff (PDF)

Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S)

American Journal of Medical Genetics, 2002, Vol.109 (4), p.328-331

2002

Volltextzugriff (PDF)

A CURIOUS FORMATION OF HORSE'S SKULL

Scientific American, 1904-07, Vol.91 (2), p.31-31

WRAITH, ED. J. C.

1904

Volltextzugriff (PDF)

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK

Orphanet journal of rare diseases, 2008-09, Vol.3 (1), p.24-24, Article 24

2008

Volltextzugriff (PDF)

A CURIOUS FORMATION OF HORSE'S SKULL

Scientific American, 1904-07, Vol.XCI (No. 2.), p.31

BY ED. J. C. WRAITH

1904

Volltextzugriff (PDF)

Mucopolysaccharidoses and the Eye

Survey of ophthalmology, 2006, Vol.51 (1), p.1-17

2006

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease

Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

Improved Metabolic Correction in Patients with Lysosomal Storage Disease Treated with Hematopoietic Stem Cell Transplant Compared with Enzyme Replacement Therapy

Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB

Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases

Evaluation of heparin cofactor II–thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice

Retrovirally mediated correction of bone marrow–derived mesenchymal stem cells from patients with mucopolysaccharidosis type I

Enzyme Replacement Therapy and Extended Newborn Screening for Mucopolysaccharidoses: Opinions of Treating Physicians

Laronidase treatment of mucopolysaccharidosis I

Limitations of enzyme replacement therapy: Current and future

The majority of MPS I patients tested raise inhibitory allo-antibodies against enzyme replacement therapy

Excess Heparan Sulphate Inhibits CXCL12-Mediated Hematopoietic Cell Migration and Engraftment After Bone Marrow Transplant in Mice with Mucopolysaccharidosis Type I

Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I

Signal One and Two Blockade Are Both Critical for Non-Myeloablative Murine HSCT across a Major Histocompatibility Complex Barrier: e77632

Novel Mutations in Sanfilippo a Syndrome: Implications for Enzyme function

Cellular Therapy of Lysosomal Storage Disorders: Current Status and Future Prospects

Mucopolysaccharidoses and Oligosaccharidoses

Treatment: Present Status and New Trends

Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S)

A CURIOUS FORMATION OF HORSE'S SKULL

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK

A CURIOUS FORMATION OF HORSE'S SKULL

Mucopolysaccharidoses and the Eye

Aktive Filter

Suchergebnisse filtern